Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.

Comirnaty targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 subvariant ...

BioNTech’s updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The ...

A factor that has changed over time is hospitalization due to severe COVID infections. On Aug. 1, the statewide seven-day ...

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

According to Suyama, in 2023 the flu killed 44,000 people nationwide, while COVID killed 74,000 people. “So COVID was nearly ...

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

Palm said October is a good time to get vaccinated. The FAA approved three new booster vaccines for COVID-19, from Pfizer, Moderna and Novavax. They target the newest strains of the coronavirus.